Browsing by Author Cervantes, Andrés
Showing results 1 to 3 of 3
| Issue Date | Title | Author(s) |
|---|---|---|
| 19-Oct-2020 | Association of Bevacizumab Plus Oxaliplatin-Based Chemotherapy With Disease-Free Survival and Overall Survival in Patients With Stage II Colon Cancer A Secondary Analysis of the AVANT Trial | Chibaudel, Benoist; Henriques, Julie; Rakez, Manel; Brenner, Baruch; Kim, Tae Won; Martínez Villacampa, Mercedes; Gallego Plazas, Javier; Cervantes, Andrés; Shim, Katharine; Jonker, Derek; Guerin Meyer, Veronique; Mineur, Laurent; Banzi, Chiara; Dewdney, Alice; Dejthevaporn, Thitiya; Bloemendal, Haiko J.; Roth, Arnaud; Moehler, Markus; Aranda, Enrique; Van Cutsem, Eric; Tabernero Caturla, Josep; Schmoll, Hans-Joachim; Hoff, Paulo M.; Andre, Thierry; Gramont, Aimery de |
| 1-Apr-2019 | Context matters-consensus molecular subtypes of colorectal cancer as biomarkers for clinical trials | Fontana, E.; Eason, K.; Cervantes, Andrés; Salazar Soler, Ramón; Sadanandam, Anguraj |
| 30-Sep-2019 | The McCAVE Trial: Vanucizumab plus mFOLFOX‐6 Versus Bevacizumab plus mFOLFOX‐6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC) | Bendell, Johanna C.; Sauri, Tamara; Gracián, Antonio Cubillo; Alvarez, Rafael; López López, Carlos; García Alfonso, Pilar; Hussein, Maen; Limon Miron, Maria Luisa; Cervantes, Andrés; Montagut Viladot, Clara; Santos, Cristina; Bessudo, Alberto; Plezia, Patricia; Moons, Veerle; Andel, Johannes; Bennouna, Jaafar; Westhuizen, Andre; Samuel, Leslie; Rossomanno, Simona; Boetsch, Christophe; Lahr, Angelika; Franjkovic, Izolda; Heil, Florian; Lechner, Katharina; Krieter, Oliver; Hurwitz, Herbert; McCAVE Study Group |